Colorectal cancer - molecular basis to targeted therapeutics. [ 2009 - 2013 ]

Also known as: Novel therapeutics for colon cancer.

Research Grant

[Cite as]

Researchers: Prof Antony Burgess (Principal investigator) ,  A/Pr Joan Heath A/Pr Martin Lackmann Dr Thomas Garrett Prof Andrew Scott
View all 9 related researchers

Brief description Cancer of the colon and rectum is the most common form of cancer in Australia. Over 12,000 people are diagnosed each year with colorectal cancer (CRC) and more than one third of people will die of their disease. CRC is caused by mistakes in production of colon cells. Our research aims to discover new ways to detect CRC, develop smart drugs and nanoparticle delivery systems for destroying all types of CRC cells. We will then test our new anti-cancer drugs in clinical trials with CRC patients.

Funding Amount $AUD 19,818,386.88

Funding Scheme Programs

Notes Program Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]